Disclosures for "The FORESITE Study: FOREcasting Seizures to Initiate ThErapy – Technical Design, Hardware, and Algorithms "
-
Dr. Brinkmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka Pharmaceuticals. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Brinkmann has a non-compensated relationship as a Co-Investigator with Medtronic Inc. that is relevant to AAN interests or activities.
-
Dr. Cui has nothing to disclose.
-
Mr. Clark has nothing to disclose.
-
Dr. Nasseri has nothing to disclose.
-
Dr. Viana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG MEDICAL.
-
Vaclav Kremen has nothing to disclose.
-
Dr. Duun-Henriksen has received personal compensation for serving as an employee of UNEEG medical.
-
Mr. McQuown has nothing to disclose.
-
Dr. Stirling has received personal compensation for serving as an employee of Seer Medical.
-
Mr. Sladky has nothing to disclose.
-
An immediate family member of Dr. Karoly has received personal compensation for serving as an employee of Seer Medical. An immediate family member of Dr. Karoly has stock in Seer Medical . The institution of Dr. Karoly has received research support from Australian government National Health and Medical Research Council . Dr. Karoly has received research support from Australian government department of industry science and resources .
-
Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
-
Andreas Schulze-Bonhage has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL, GW. Andreas Schulze-Bonhage has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIAL, GW, EISAI, UCB.
-
The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.